批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/03/28 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/12/01 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/09/15 |
SUPPL-39(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2016/03/22 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/03/10 |
SUPPL-38(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/07/17 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/27 |
SUPPL-36(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2013/10/29 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/08/28 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/03/05 |
SUPPL-32(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/02/12 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/04/27 |
SUPPL-28(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2012/02/17 |
SUPPL-29(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2011/05/10 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/04/26 |
SUPPL-24(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/09/11 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/04/14 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/04/30 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/03/05 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/02/20 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/12/14 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/12/13 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/10/12 |
SUPPL-13(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2007/02/07 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/11/14 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/08/07 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/05/11 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/03/10 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/11/10 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/06/13 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/11/29 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/10/20 |
ORIG-1(原始申请) |
Approval |
Type 2 - New Active Ingredient |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:FOSAMPRENAVIR CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 700MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021548 |
001 |
NDA |
LEXIVA |
FOSAMPRENAVIR CALCIUM |
TABLET;ORAL |
EQ 700MG BASE |
Discontinued |
Yes |
No |
AB |
2003/10/20
|
VIIV HLTHCARE |
204060 |
001 |
ANDA |
FOSAMPRENAVIR CALCIUM |
FOSAMPRENAVIR CALCIUM |
TABLET;ORAL |
EQ 700MG BASE |
Prescription |
No |
Yes |
AB |
2016/04/15
|
MYLAN |
204024 |
001 |
ANDA |
FOSAMPRENAVIR CALCIUM |
FOSAMPRENAVIR CALCIUM |
TABLET;ORAL |
EQ 700MG BASE |
Prescription |
No |
No |
AB |
2019/11/20
|
SUN PHARM |